Hem CME/CE Courses – Update

Hematology CME/CE Courses

Powered by myCME

Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

$Emergence of Chemotherapy-Free Regimens for Previously Untreated and Relapsed/Refractory CLL: Highlights from ASCO 2019$

Emerging Targeted-Specific CLL Regimens: ASCO Highlights 2019

AMA PRA Category 1 Credit(s)^TM

CITY OF HOPE: State of the Art of Cancer Therapeutics: Focus on Chronic Lymphocytic Leukemia

State of the Art of Cancer Therapeutics: Chronic Lymphocytic Leukemia

AMA PRA Category 1 Credit(s)^TM

$CITY OF HOPE: State of the Art of Cancer Therapeutics: Focus on Relapsed/Refractory Multiple Myeloma$

State of the Art of Cancer Therapeutics: Relapsed/Refractory Multiple Myeloma

AMA PRA Category 1 Credit(s)^TM

$Practicing in an Era of Chemotherapy-Free Regimens for Relapsed/Refractory Chronic Lymphocytic Leukemia$

Practicing in an Era of Chemo-Free Regimens for R/R CLL

AMA PRA Category 1 Credit(s)^TM

Hematology Consults: Optimizing Diagnosis and Treatment for Patients with Peripheral T-Cell Lymphoma

Optimizing Diagnosis and Treatment for Patients with PTCL

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

More Courses

At-risk Populations and Prevention of HPV-related Cancers

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

Hematology Consults: Chimeric Antigen Receptor Therapies (CAR-Ts) and their Potential Impact on Hematologic Cancer Care

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

MCL Patient Exam in the Era of Targeted Therapies

AMA PRA Category 1 Credit(s)^TM

New Paradigms in the Treatment of CLL and CML

AMA PRA Category 1 Credit(s)^TM, CE for Nurses

New Paradigms in the Treatment of AML and ALL

AMA PRA Category 1 Credit(s)^TM, CE for Nurses

Increasing Awareness of Biosimilars

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

Shaping the Future of Myeloma Treatment

AMA PRA Category 1 Credit(s)^TM

CTCA Forum 2019 Highlights

AMA PRA Category 1 Credit(s)^TM

Emerging Targeted-Specific CLL Regimens: ASCO Highlights 2019

AMA PRA Category 1 Credit(s)^TM

Multi-Targeted Tyrosine Kinase Inhibitors and Immunotherapy Options for HCC

AMA PRA Category 1 Credit(s)^TM, CE for Nurses

Next hm-section-front in CME

General CME/CE Courses